Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Smoking increases early hair loss risk in men; quitting may help prevent it.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Women with PCOS who have high male hormone levels often also have insulin resistance.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Reassurance is important for postpartum hair shedding as it likely won't cause complete baldness.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Early onset hair loss in young men is common and linked to family history and alcohol use.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Pregnancy and nursing increase certain brain activities in rats, but these changes disappear when the babies are taken away.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

New genes and pathways are important for testosterone production and male sexual development.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.